Journal article
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease
Abstract
OBJECTIVES: Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract. Symptoms include but are not limited to abdominal pain, nausea, emesis, and diarrhea. Anti-TNF-α drugs are increasingly being used in patients with CD who have inadequate response to conventional therapy. However, these medications are quite expensive. The objective of this study is to evaluate the cost-utility of two anti-TNF-α drugs (infliximab, …
Authors
Blackhouse G; Assasi N; Xie F; Marshall J; Irvine EJ; Gaebel K; Campbell K; Hopkins R; O’Reilly D; Tarride J-E
Journal
Journal of Crohn's and Colitis, Vol. 6, No. 1, pp. 77–85
Publisher
Oxford University Press (OUP)
Publication Date
February 2012
DOI
10.1016/j.crohns.2011.07.007
ISSN
1197-4982